June 2022
Volume 63, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2022
Characterization of two-year progression of risk phenotypes of diabetic retinopathy
Author Affiliations & Notes
  • Maria Luísa Ribeiro
    AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Inês Marques
    AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Sónia Ferreira
    AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
  • Ana Rita Santos
    AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Torcato Santos
    AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
  • Jose G Cunha-Vaz
    AIBILI - Association for Innovation and Biomedical Research on Light and Image, Coimbra, Portugal
    Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine, University of Coimbra, Coimbra, Portugal
  • Footnotes
    Commercial Relationships   Maria Luísa Ribeiro None; Inês Marques None; Sónia Ferreira None; Ana Rita Santos None; Torcato Santos None; Jose Cunha-Vaz Carl Zeiss Meditec, Ciana Therapeutics, Allergan, Bayer, Roche, Adverum Biotechnologies, NovaGo Therapeutics, Emerton, Code C (Consultant/Contractor)
  • Footnotes
    Support  PTDC/MEC-OFT/30375/2017
Investigative Ophthalmology & Visual Science June 2022, Vol.63, 2504 – F0230. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Maria Luísa Ribeiro, Inês Marques, Sónia Ferreira, Ana Rita Santos, Torcato Santos, Jose G Cunha-Vaz; Characterization of two-year progression of risk phenotypes of diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2022;63(7):2504 – F0230.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To characterize the two-years progression of two diabetic retinopathy (DR) risk phenotypes in type 2 diabetes (T2D).

Methods : A prospective longitudinal cohort study (CORDIS, NCT03696810) was conducted with 4 visits (baseline, 6-months, one-year and two-year). Demographic and systemic data included age, sex, diabetes duration, lipidic profile and hemoglobin A1c (HbA1c). Ophthalmological examinations including visual acuity (BCVA), color fundus photography (CFP) and optical coherence tomography (OCT and OCTA), identified the presence of nonproliferative diabetic retinopathy (NPDR). Phenotype classification was performed, at 6-month visit, based on microaneurysm turnover (MAT, on CFP) and central retinal thickness (CRT, on OCT). Only risk phenotypes B (MAT<6 and increased CRT) and C (MAT≥6 with or without increased CRT) were included. ETDRS grading was performed at the baseline and last visits based on 7-fields CFP.

Results : 133 T2D individuals were included in the study, 81 (60%) eyes classified as phenotype B and 52 (40%) eyes as phenotype C. Of these, 127 completed the two-year follow-up, 24 (19%) developed central-involved macular edema (CIME) and 2 clinically significant macular edema (CSME) (1.6%). In the two-year period, two-step severity progression (ETDRS) occurred only in one eye with phenotype C.
At baseline, eyes with phenotype C showed more capillary closure in the superficial capillary plexus (SCP), deep capillary plexus (DCP) and full retina (FR, p<0,001) and increased FAZ area (p<0,001), indicating more advanced microvascular disease and confirming the ischemia phenotype. During the two-year period both phenotypes, B and C, showed progression in GCL+IPL thinning (p<0,001) and decrease in vessel density in the DCP (<0,001). When analyzing the two-year progression of each phenotype, only phenotype C revealed significant decrease in BCVA (p=0,02) and enlargement of the FAZ (p=0,03). CSME developed only in phenotype C whereas CIME occurred in both risk phenotypes.

Conclusions : In the two-year period of follow-up both phenotypes B and C showed progression in retinal neurodegeneration associated with progression in capillary closure identified by progressive decrease in vessel density of the DCP. CIME developed in both phenotypes and CSME only in phenotype C.

This abstract was presented at the 2022 ARVO Annual Meeting, held in Denver, CO, May 1-4, 2022, and virtually.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×